|
|
U Kabelovny 130 Praha 10, 102 37 Czech Republic phone:(420) 267 241 111 fax:(420) 272 702 402
|
|
| Symbol |
BAAZEN |
| Exchange |
PRG |
| Founded |
2003 |
| Employees |
|
|
|
| www.zentiva.cz
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| International pharma company - branded generic pharma products |
 |
| Management |
| iri Michal, Chairman, Director; Bart Filius, Dicertor; Belen Garijo, Director; Urs Kamber, Director; Philippe Luscan, Director |
| |
|
|
|
|
|
|
| |
|
|
|
|
| Keywords |
| healthcare, generic, sanofi, vitamin, slovakia |
|
|
|
|
|
|
| Description |
|
Zentiva is a modern pharmaceutical group specializing in the development, manufacturing and marketing of branded equivalents. We hold leading positions in the Czech, Turkish, Romanian, Polish, Slovak and Russian markets and are an important player in the Central and Eastern European region.. Made up of more than 400 products in the form of 800 drug forms, the product portfolio covers a wide range of therapeutic areas. Products of the Zentiva group are intended for pain treatment, cardiovascular diseases, disorders of central nervous system, digestion system, urinary tract and genital system, and treatment of respiratory diseases. The key product in the area of food supplements are vitamin preparations. It is part of the Sanofi-Aventis group. |
 |
| Technology / Differentiation |
| The Zentiva Group addresses a large number of therapeutic areas, but it focuses, in particular, on the treatment of cardiovascular disorders, inflammatory conditions, pain, infections and diseases of the central nervous system and the gastrointestinal and urinary tracts. |
 |
 |
|
|
|
|
|
|